Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis

Condition:   Multiple Sclerosis Interventions:   Drug: IMU-838;   Drug: Placebo matching IMU-838 Sponsor:   Immunic AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials